Azenta Acquires UK Biocentre Limited to Expand European Biorepository Capabilities

Azenta Completes Sale of B Medical Systems to Thelema S.à r.l.

July 9, 2026

Medical Devices

Azenta has completed the sale of its B Medical Systems business to Thelema S.à r.l., closing the transaction on July 1, 2026 after all required conditions were satisfied. Azenta sold B Medical Systems for a fixed $63 million in cash, with $35 million financed through a short-term secured vendor loan provided by an Azenta subsidiary to Thelema.

AstraZeneca to Acquire EsoBiotec

March 18, 2025

Biotechnology

AstraZeneca has entered into a definitive agreement to acquire EsoBiotec, a biotechnology company developing in vivo cell therapies. The deal is valued at up to $1 billion on a cash and debt-free basis, with an initial $425 million payment upon closing plus up to $575 million in contingent milestone consideration. The transaction is expected to close in Q2 2025, subject to regulatory approvals.

Bruker Corporation Acquires ZONTAL Inc.

May 8, 2023

Software

Bruker Corporation has closed the acquisition of ZONTAL Inc., a provider of a GxP-compliant life-sciences data platform, to strengthen Bruker BioSpin's Integrated Data Solutions (IDS) software portfolio. The deal (terms not disclosed) will integrate ZONTAL's vendor-agnostic laboratory and process data management capabilities with Bruker's Mestrelab, Arxspan and Optimal offerings to accelerate digital laboratory transformation for biopharma and life-science customers; ZONTAL expected 2023 revenues of greater than $5 million.

Azenta, Inc. Acquires Ziath, Ltd.

February 3, 2023

Medical Devices

Azenta, Inc. (Nasdaq: AZTA) has acquired Ziath, Ltd., a Cambridge, UK–based provider of 2D barcode readers for life sciences laboratory applications. Ziath will join Azenta's Life Sciences Products business (Consumables and Instruments); CEO and co-founder Neil Benn will continue to lead the business, and the deal is expected to be accretive to non-GAAP earnings in FY2023 and GAAP earnings in FY2024.

Discovery Life Sciences Acquires East West Biopharma

November 9, 2020

Healthcare Services

Discovery Life Sciences acquired East West Biopharma, a European human biospecimen contract research organization with a large biocollection network in Ukraine. The deal expands Discovery’s biospecimen collection and clinical site footprint across Europe, strengthening its global position as a leading provider of biospecimen and related scientific services.

Arranta Bio Acquires Captozyme

November 13, 2019

Biotechnology

Arranta Bio has acquired Captozyme and integrated its Gainesville, Florida team and facilities to create a Center of Excellence for microbiome process and analytical development and early clinical supply. The acquisition expands Arranta's CDMO capabilities for live biotherapeutics and transfers Captozyme's clinical GMP capacity while Captozyme's enzyme therapeutic assets were spun out into Oxidien Pharmaceuticals.